| Literature DB >> 34733919 |
Zhitao Chen1,2,3, Weiqiang Ju1,2,3, Chuanbao Chen1,2,3, Tielong Wang1,2,3, Jia Yu1,2,3, Xitao Hong1,2,3, Yuqi Dong1,2,3, Maogen Chen1,2,3, Xiaoshun He1,2,3.
Abstract
BACKGROUND: Surgical techniques of liver transplantation have continually evolved and have been modified. We retrospectively analyzed a single-center case series and compared the advantages and disadvantages of each method.Entities:
Keywords: Surgical techniques; classic piggyback; early allograft dysfunction; liver transplantation (LT); outflow venous obstruction
Year: 2021 PMID: 34733919 PMCID: PMC8506559 DOI: 10.21037/atm-21-1945
Source DB: PubMed Journal: Ann Transl Med ISSN: 2305-5839
Figure 1Information about recipient in our study. (A) The study flowchart. (B) Components of participants in our study.
Figure 2Various surgical techniques in orthotopic liver transplantation. (A) Modified classic; (B) modified piggyback; (C) classic piggyback.
Preoperative data for patients transplanted in different techniques (n=674)
| Variable | Total (n=674) | Surgical techniques | P | ||
|---|---|---|---|---|---|
| MC (n=282) | MPB (n=291) | CPB (n=101) | |||
| Gender (male/female) | 585/89 | 252/30 | 253/38 | 80/21 | 0.035 |
| Age (ys) | 48.82±0.50 | 48.65±0.77 | 48.22±0.80 | 51.02±1.11 | 0.170 |
| Height (cm) | 166.23±0.54 | 1.66.76±0.84 | 165.31±0.93 | 167.43±0.72 | 0.307 |
| Weight (kg) | 64.54±0.53 | 64.76±0.79 | 63.99±0.86 | 65.44±1.15 | 0.610 |
| Creatinine (μmol/L) | 91.99±3.31 | 90.63±4.15 | 89.15±5.04 | 104.00±11.89 | 0.307 |
| Albumin (g/L) | 36.56±0.55 | 35.61±0.43 | 37.50±1.17 | 36.52±0.81 | 0.287 |
| Total bilirubin (μmol/L) | 160.40±8.20 | 141.60±11.50 | 165.19±13.14 | 199.12±22.68 | 0.058 |
| MELD score | 17.55±0.37 | 16.58±0.55 | 17.63±0.58 | 20.06±0.98 | 0.008 |
| Child-Pugh score | 8.41±0.09 | 8.20±0.14 | 8.38±0.14 | 9.11±0.23 | 0.003 |
| Respiratory diseases, n (%) | 9 (1.3) | 3 (0.4) | 4 (0.6) | 2 (0.3) | 0.787 |
| Hypertension, n (%) | 77 (11.4) | 38 (5.6) | 31 (4.6) | 8 (1.2) | 0.277 |
| Diabetes, n (%) | 86 (12.8) | 42 (6.2) | 34 (5.0) | 10 (1.5) | 0.333 |
| Previous abdominal surgery, n (%) | 177 (26.3) | 74 (11.0) | 86 (12.8) | 17 (2.5) | 0.044 |
MC, modified classic; MPB, modified piggyback; CPB, classic piggyback; MELD, Model for End-Stage Liver Disease.
Perioperative characteristics of patients transplanted in different techniques (n=674)
| Variable | Total (n=674) | Median | Surgical techniques | P | ||
|---|---|---|---|---|---|---|
| MC (n=282) | MPB (n=291) | CPB (n=101) | ||||
| Anhepatic time (min) | 56.16±0.76 | 54.00 | 56.01±1.17 | 57.43±1.20 | 52.88±1.76 | 0.136 |
| Cold ischemia time (min) | 416.88±6.96 | 416.50 | 409.63±11.43 | 431.53±9.35 | 394.91±20.19 | 0.146 |
| Operation duration (min) | 466.16±4.36 | 450.00 | 455.04±6.64 | 483.08±6.98 | 448.46±9.28 | 0.003 |
| RBC volume (mL) | 1,375.46±57.14 | 1,000.00 | 1,262.22±73.38 | 1,416.29±99.71 | 1,574.00±143.31 | 0.0159 |
| FFP volume (mL) | 1,978.74±56.73 | 1,600.00 | 2,033.05±82.07 | 1,980.00±95.37 | 1,823.47±123.96 | 0.472 |
| Platelet volume (u) | 7.57±2.16 | 0 | 9.93±4.41 | 5.88±2.37 | 5.88±3.19 | 0.653 |
| Blood loss (mL) | 2,368.07±95.54 | 1,500.00 | 2,116.70±127.12 | 2,477.84±153.03 | 2,753.66±289.65 | 0.052 |
| Ventilation time (hr) | 44.99±8.00 | 14.00 | 36.22±4.18 | 40.11±4.32 | 84.36±51.46 | 0.120 |
| Duration of oral in-take (hr) | 130.06±5.51 | 34.50 | 133.44±9.30 | 127.13±8.42 | 128.06±9.88 | 0.099 |
| ICU stay time (hr) | 77.63±8.67 | 100.00 | 66.18±6.30 | 73.53±7.45 | 121.11±50.45 | 0.862 |
| Abdominal bleeding, n (%) | 35 (5.2) | – | 17 (2.5) | 12 (1.8) | 6 (0.9) | 0.552 |
| HAT, n (%) | 30 (4.5) | – | 14 (2.1) | 14 (2.1) | 2 (0.3) | 0.425 |
| PVT, n (%) | 7 (1.0) | – | 1 (0.1) | 4 (0.6) | 2 (0.3) | 0.290 |
| Outflow obstruction, n (%) | 3 (0.4) | – | 0 | 1 (0.1) | 2 (0.3) | 0.035 |
| AKI, n (%) | 27 (4.0) | – | 11 (1.6) | 11 (1.6) | 5 (0.7) | 0.869 |
| PNF, n (%) | 10 (1.5) | – | 5 (0.7) | 4 (0.6) | 1 (0.1) | 0.838 |
| EAD, n (%) | 131 (19.4) | – | 58 (8.6) | 49 (7.3) | 24 (3.6) | 0.260 |
| Hospital stays (d) | 29.07±21.01 | 24.00 | 30.52±1.65 | 28.82±1.01 | 25.71±1.38 | 0.166 |
| Death in 30 days, n (%) | 54 (8.0) | – | 22 (3.3) | 22 (3.3) | 10 (1.5) | 0.746 |
| Death in 90 days, n (%) | 76 (11.3) | – | 31 (4.6) | 32 (4.7) | 13 (1.9) | 0.860 |
MC, modified classic; MPB, modified piggyback; CPB, classic piggyback; RBC, red blood cell; FFP, Fresh Frozen Plasma. ICU, intensive care unit; HAT, hepatic artery thrombosis; PVT, portal vein thrombosis; PNF, primary nonfunction; EAD, early allograft dysfunction; AKI, acute kidney injury.
Figure 3Perioperative comparison in three groups. (A) Anhepatic time, cold ischemia time and operation time (B) RBC transfusion, FFP transfusion and blood loss; (C) ventilation time, duration of oral in-take and ICU stay time; (D) abdominal bleeding, HAT, PVT, outflow obstruction and AKI; (E) EAD, PNF, 30- and 90-day death. *means P<0.05. FFP, fresh frozen plasma; ICU, intensive care unit; HAT, hepatic artery thrombosis; PVT, portal vein thrombosis; AKI, acute kidney injury; EAD, early allograft dysfunction; PNF, primary nonfunction.
Figure 4Kaplan-Meier survival analyses in total and subgroups. (A) Total; (B) combined tumor; (C) no tumor; (D) hepatocellular carcinoma; (E) simple cirrhosis; (F) history of abdominal surgery; (G) preoperative creatinine >120 µmol/L; (H) normal preoperative creatinine; (I) MELD >24. MELD, model for end stage liver disease.
Multivariant analysis on cause of death within 30 days and 90 days patients transplanted with different techniques
| Variants | Multivariant analysis | ||||
|---|---|---|---|---|---|
| 30 days mortality | 90 days mortality | ||||
| RR (95% CI) | P | RR (95% CI) | P | ||
| Surgical techniques | 1.026 (0.901–1.169) | 0.696 | 1.024 (0.897–1.171) | 0.723 | |
| Cirrhosis | 0.917 (0.749–1.123) | 0.403 | 0.950 (0.772–1.169) | 0.630 | |
| Acute liver failure | 0.654 (0.374–1.145) | 0.137 | 0.647 (0.362–1.156) | 0.142 | |
| Pretransplant diagnosis with tumor | 1.326 (1.116–1.576) | 0.001* | 1.349 (1.132–1.608) | 0.001* | |
| Abdominal bleeding | 1.309 (0.871–1.967) | 0.195 | 1.207 (0.783–1.860) | 0.395 | |
| HAT | 1.141 (0.766–1.698) | 0.516 | 1.142 (0.761–1.713) | 0.522 | |
| PVT | 0.623 (0.232–1.670) | 0.347 | 0.622 (0.232–1.668) | 0.345 | |
| Outflow obstruction | 3.729 (0.923–15.064) | 0.065 | 2.104 (0.294–15.068) | 0.459 | |
| EAD | 1.835 (1.489–2.262) | 0.001* | 1.822 (1.469–2.259) | <0.001* | |
| AKI | 1.009 (0.611–1.666) | 0.973 | 0.762 (0.428–1.356) | 0.355 | |
*P<0.05. MC, modified classic; MPB, modified piggyback; CPB, classic piggyback; HAT, hepatic artery thrombosis; PVT, portal vein thrombosis; PNF, primary nonfunction; EAD, early allograft dysfunction; AKI, acute kidney injury.